Range
- - -
Vol / Avg.
-/1.9M
Div / Yield
-
52 Wk
34.43 - 64.37
Mkt Cap
5.3B
Payout Ratio
-
Open
-
P/E
-
EPS
-0.64
Shares
141M
Outstanding
141M
Total Float
118.9M
Sector: Health Care.Industry: Biotechnology
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS-0.530-0.320 0.2100
REV112.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
IONSIonis Pharmaceuticals1.24%5.3B

Ionis Pharmaceuticals Frequently Asked Questions

Q

How do I buy Ionis Pharmaceuticals (IONS) stock?

A

You can purchase shares of Ionis Pharmaceuticals (NASDAQ: IONS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ionis Pharmaceuticals's (IONS) competitors?

Q

What is the target price for Ionis Pharmaceuticals (IONS) stock?

A

The latest price target for Ionis Pharmaceuticals (NASDAQ: IONS) was reported by SVB Leerink on May 14, 2021. The analyst firm set a price target for 41.00 expecting IONS to rise to within 12 months (a possible 8.52% upside). 18 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ionis Pharmaceuticals (IONS)?

A

The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $37.78 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Ionis Pharmaceuticals (IONS) pay a dividend?

A

There are no upcoming dividends for Ionis Pharmaceuticals.

Q

When is Ionis Pharmaceuticals (NASDAQ:IONS) reporting earnings?

A
Ionis Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Ionis Pharmaceuticals (IONS) going to split?

A

There is no upcoming split for Ionis Pharmaceuticals.

Q

What sector and industry does Ionis Pharmaceuticals (IONS) operate in?

A

Ionis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.